<?xml version="1.0" encoding="UTF-8" standalone="no"?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" version="2.0"><channel><title>PolygenicBlog</title><description>Concerning the relationships between genes, risk factors and immunity in Alzheimer's disease, Autism, Bipolar disorder , multiple sclerosis, Parkinson's disease, schizophrenia and chronic fatigue</description><managingEditor>noreply@blogger.com (Chris Carter)</managingEditor><pubDate>Tue, 14 Apr 2026 08:31:05 +0100</pubDate><generator>Blogger http://www.blogger.com</generator><openSearch:totalResults xmlns:openSearch="http://a9.com/-/spec/opensearchrss/1.0/">6529</openSearch:totalResults><openSearch:startIndex xmlns:openSearch="http://a9.com/-/spec/opensearchrss/1.0/">1</openSearch:startIndex><openSearch:itemsPerPage xmlns:openSearch="http://a9.com/-/spec/opensearchrss/1.0/">25</openSearch:itemsPerPage><link>http://polygenicpathways.blogspot.com/</link><language>en-us</language><itunes:explicit>no</itunes:explicit><itunes:image href="http://www.polygenicpathways.co.uk/disc1.jpg"/><itunes:keywords>Alzheimer,s,schizophrenia,chronic,fatigue,prostate,cancer,bipolar,disorder,XMRV,Herpes,simplex,virus,multiple,sclerosis,parkinson,s,disease</itunes:keywords><itunes:subtitle>PolyBlog</itunes:subtitle><itunes:category text="Science &amp; Medicine"><itunes:category text="Medicine"/></itunes:category><itunes:author>Chris Carter</itunes:author><itunes:owner><itunes:email>noreply@blogger.com</itunes:email><itunes:name>Chris Carter</itunes:name></itunes:owner><item><title>Artificially Sweetened Beverages and Stroke, Coronary Heart Disease, and All-Cause Mortality in the Women’s Health Initiative | Stroke</title><link>http://polygenicpathways.blogspot.com/2019/03/artificially-sweetened-beverages-and.html</link><category>artificial sweeteners</category><category>stroke</category><pubDate>Thu, 14 Mar 2019 06:23:00 GMT</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-9080680274793928567.post-1802637643156257808</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
&lt;div class="abstractSection abstractInFull"&gt;
&lt;h3 class="article-section__title" id="d3e350"&gt;
Background and Purpose—&lt;/h3&gt;
We examine the association between self-reported consumption of &lt;br /&gt;
artificially sweetened beverages (ASB) and stroke and its subtypes, &lt;br /&gt;
coronary heart disease, and all-cause mortality in a cohort of &lt;br /&gt;
postmenopausal US women.&lt;br /&gt;
&lt;h3 class="article-section__title" id="d3e359"&gt;
Methods—&lt;/h3&gt;
The analytic cohort included 81 714 women from the Women’s Health &lt;br /&gt;
Initiative Observational Study, a multicenter longitudinal study of the &lt;br /&gt;
health of 93 676 postmenopausal women of ages 50 to 79 years at baseline&lt;br /&gt;
who enrolled in 1993 to 1998. This prospective study had a mean &lt;br /&gt;
follow-up time of 11.9 years (SD of 5.3 years.) Participants who &lt;br /&gt;
completed a follow-up visit 3 years after baseline were included in the &lt;br /&gt;
study.&lt;br /&gt;
&lt;br /&gt;
&lt;h3 class="article-section__title" id="d3e368"&gt;
Results—&lt;/h3&gt;
Most participants (64.1%) were infrequent consumers (never or &amp;lt;1/week) of&lt;br /&gt;
ASB, with only 5.1% consuming ≥2 ASBs/day. In multivariate analyses, &lt;br /&gt;
those consuming the highest level of ASB compared to never or rarely &lt;br /&gt;
(&amp;lt;1/wk) had significantly greater likelihood of all end points &lt;br /&gt;
(except hemorrhagic stroke), after controlling for multiple covariates. &lt;br /&gt;
Adjusted models indicated that hazard ratios and 95% confidence &lt;br /&gt;
intervals were 1.23 (1.02–1.47) for all stroke; 1.31 (1.06–1.63) for &lt;br /&gt;
ischemic stroke; 1.29 (1.11–1.51) for coronary heart disease; and 1.16 &lt;br /&gt;
(1.07–1.26) for all-cause mortality. In women with no prior history of &lt;br /&gt;
cardiovascular disease or diabetes mellitus, high consumption of ASB was&lt;br /&gt;
associated with more than a 2-fold increased risk of small artery &lt;br /&gt;
occlusion ischemic stroke hazard ratio =2.44 (95% confidence interval, &lt;br /&gt;
1.47–4.04.) High consumption of ASBs was associated with significantly &lt;br /&gt;
increased risk of ischemic stroke in women with body mass index ≥30; &lt;br /&gt;
hazard ratio =2.03 (95% confidence interval, 1.38–2.98).&lt;br /&gt;
&lt;br /&gt;
&lt;h3 class="article-section__title" id="d3e377"&gt;
Conclusions—&lt;/h3&gt;
Higher&lt;br /&gt;
intake of ASB was associated with increased risk of stroke, &lt;br /&gt;
particularly small artery occlusion subtype, coronary heart disease, and&lt;br /&gt;
all-cause mortality. Although requiring replication, these new findings&lt;br /&gt;
add to the potentially harmful association of consuming high quantities&lt;br /&gt;
of ASB with these health outcomes.&lt;/div&gt;
&lt;/div&gt;
&lt;div class="blogger-post-footer"&gt;pub-5799224524264318&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><author>noreply@blogger.com (Chris Carter)</author></item><item><title>Autism genes and the leukocyte transcriptome in autistic toddlers relate to pathogen interactomes, infection and the immune system. A role for excess neurotrophic sAPPα and reduced antimicrobial Aβ - ScienceDirect</title><link>http://polygenicpathways.blogspot.com/2019/03/autism-genes-and-leukocyte.html</link><category>autism</category><category>Beta amyloid</category><category>infection</category><category>pathogen</category><pubDate>Wed, 13 Mar 2019 10:37:00 GMT</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-9080680274793928567.post-4134577860572976897</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
Prenatal and early childhood infections have been implicated in autism. &lt;br /&gt;
Many autism susceptibility genes (206 Autworks genes) are localised in &lt;br /&gt;
the immune system and are related to immune/infection pathways. They are&lt;br /&gt;
enriched in the host/pathogen interactomes of 18 separate microbes &lt;br /&gt;
(bacteria/viruses and fungi) and to the genes regulated by bacterial &lt;br /&gt;
toxins, mycotoxins and Toll-like receptor ligands. This enrichment was &lt;br /&gt;
also observed for misregulated genes from a microarray study of &lt;br /&gt;
leukocytes from autistic toddlers. The upregulated genes from this &lt;br /&gt;
leukocyte study also matched the expression profiles in response to &lt;br /&gt;
numerous infectious agents from the Broad Institute molecular signatures&lt;br /&gt;
database. They also matched genes related to sudden infant death &lt;br /&gt;
syndrome and autism comorbid conditions (autoimmune disease, systemic &lt;br /&gt;
lupus erythematosus, diabetes, epilepsy and cardiomyopathy) as well as &lt;br /&gt;
to estrogen and thyrotropin responses and to those upregulated by &lt;br /&gt;
different types of stressors including oxidative stress, hypoxia, &lt;br /&gt;
endoplasmic reticulum stress, ultraviolet radiation or &lt;br /&gt;
2,4-dinitrofluorobenzene, a hapten used to develop allergic skin &lt;br /&gt;
reactions in animal models. The oxidative/integrated stress response is &lt;br /&gt;
also upregulated in the autism brain and may contribute to myelination &lt;br /&gt;
problems. There was also a marked similarity between the expression &lt;br /&gt;
signatures of autism and Alzheimer's disease, and 44 shared &lt;br /&gt;
autism/Alzheimer's disease genes are almost exclusively expressed in the&lt;br /&gt;
blood-brain barrier. However, in contrast to Alzheimer's disease, &lt;br /&gt;
levels of the antimicrobial peptide beta-amyloid are decreased and the &lt;br /&gt;
levels of the neurotrophic/myelinotrophic soluble APP alpha are &lt;br /&gt;
increased in autism, together with an increased activity of α-secretase.&lt;br /&gt;
sAPPα induces an increase in glutamatergic and a decrease in GABA-ergic&lt;br /&gt;
synapses creating and excitatory/inhibitory imbalance that has also &lt;br /&gt;
been observed in autism. A literature survey showed that multiple autism&lt;br /&gt;
genes converge on APP processing and that many are able to increase &lt;br /&gt;
sAPPalpha at the expense of beta-amyloid production. A genetically &lt;br /&gt;
programmed tilt of this axis towards an overproduction of &lt;br /&gt;
neurotrophic/gliotrophic sAPPalpha and underproduction of antimicrobial &lt;br /&gt;
beta-amyloid may explain the brain overgrowth and myelination &lt;br /&gt;
dysfunction, as well as the involvement of pathogens in autism.&lt;/div&gt;
&lt;div class="blogger-post-footer"&gt;pub-5799224524264318&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><author>noreply@blogger.com (Chris Carter)</author></item><item><title>Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors | Science Advances</title><link>http://polygenicpathways.blogspot.com/2019/01/porphyromonas-gingivalis-in-alzheimers.html</link><category>Alzheimer's disease</category><category>periodontitis</category><category>Porphyromonas gingivalis</category><pubDate>Thu, 24 Jan 2019 13:48:00 GMT</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-9080680274793928567.post-7042644676690186628</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
&amp;nbsp;Porphyromonas gingivalis , the keystone pathogen in chronic periodontitis, was identified in the brain of Alzheimer’s disease patients. Toxic proteases from the bacterium called gingipains were also identified in the brain of Alzheimer’s patients, and levels correlated with tau and ubiquitin pathology. Oral P. gingivalis infection in mice resulted in brain colonization and increased production of Aβ1–42, a component of amyloid plaques. Further, gingipains were neurotoxic in vivo and in vitro, exerting detrimental effects on tau, a protein needed for normal neuronal function. To block this neurotoxicity, we designed and synthesized small-molecule inhibitors targeting gingipains. Gingipain inhibition reduced the bacterial load of an established P. gingivalis brain infection, blocked Aβ1–42 production, reduced neuroinflammation, and rescued neurons in the hippocampus. These data suggest that gingipain inhibitors could be valuable for treating P. gingivalis brain colonization and neurodegeneration in Alzheimer’s disease.&lt;/div&gt;
&lt;div class="blogger-post-footer"&gt;pub-5799224524264318&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><author>noreply@blogger.com (Chris Carter)</author></item><item><title>Microglia and amyloid precursor protein coordinate control of transient Candida cerebritis with memory deficits | Nature Communications</title><link>http://polygenicpathways.blogspot.com/2019/01/microglia-and-amyloid-precursor-protein.html</link><category>Alzheimer's disease</category><category>Beta amyloid</category><category>candida</category><pubDate>Fri, 4 Jan 2019 20:46:00 GMT</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-9080680274793928567.post-6736522476450243689</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
Bloodborne infections with &lt;i&gt;Candida albicans&lt;/i&gt; are an increasingly &lt;br /&gt;
recognized complication of modern medicine. Here, we present a mouse &lt;br /&gt;
model of low-grade candidemia to determine the effect of disseminated &lt;br /&gt;
infection on cerebral function and relevant immune determinants. We show&lt;br /&gt;
that intravenous injection of 25,000 &lt;i&gt;C. albicans&lt;/i&gt; cells causes a &lt;br /&gt;
highly localized cerebritis marked by the accumulation of activated &lt;br /&gt;
microglial and astroglial cells around yeast aggregates, forming &lt;br /&gt;
fungal-induced glial granulomas. Amyloid precursor protein accumulates &lt;br /&gt;
within the periphery of these granulomas, while cleaved amyloid beta &lt;br /&gt;
(Aβ) peptides accumulate around the yeast cells. CNS-localized &lt;i&gt;C. albicans&lt;/i&gt;&lt;br /&gt;
further activate the transcription factor NF-κB and induce production &lt;br /&gt;
of interleukin-1β (IL-1β), IL-6, and tumor necrosis factor (TNF), and Aβ&lt;br /&gt;
peptides enhance both phagocytic and antifungal activity from BV-2 &lt;br /&gt;
cells. Mice infected with &lt;i&gt;C. albicans&lt;/i&gt; display mild memory &lt;br /&gt;
impairment that resolves with fungal clearance. Our results warrant &lt;br /&gt;
additional studies to understand the effect of chronic cerebritis on &lt;br /&gt;
cognitive and immune function.&lt;/div&gt;
&lt;div class="blogger-post-footer"&gt;pub-5799224524264318&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><author>noreply@blogger.com (Chris Carter)</author></item><item><title>A Nationwide Study in Denmark of the Association Between Treated Infections and the Subsequent Risk of Treated Mental Disorders in Children and Adolescents | Adolescent Medicine | JAMA Psychiatry | JAMA Network</title><link>http://polygenicpathways.blogspot.com/2018/12/a-nationwide-study-in-denmark-of.html</link><category>infection</category><category>Mental health</category><category>mental illness</category><pubDate>Thu, 6 Dec 2018 08:45:00 GMT</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-9080680274793928567.post-8761624446242865256</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
&lt;b&gt;Importance&lt;/b&gt;&lt;br /&gt;
Infections have been associated with increased risks for &lt;br /&gt;
mental disorders, such as schizophrenia and depression. However, the &lt;br /&gt;
association between all infections requiring treatment and the wide &lt;br /&gt;
range of mental disorders is unknown to date.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Objective&lt;/b&gt;&lt;br /&gt;
To investigate the association between all treated infections &lt;br /&gt;
since birth and the subsequent risk of development of any treated mental&lt;br /&gt;
 disorder during childhood and adolescence.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Design, Setting, and Participants&lt;/b&gt;&lt;br /&gt;
Population-based cohort study using Danish nationwide &lt;br /&gt;
registers. Participants were all individuals born in Denmark between &lt;br /&gt;
January 1, 1995, and June 30, 2012 (N = 1 098 930). Dates of analysis &lt;br /&gt;
were November 2017 to February 2018.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Exposures&lt;/b&gt;&lt;br /&gt;
All treated infections were identified in a time-varying &lt;br /&gt;
manner from birth until June 30, 2013, including severe infections &lt;br /&gt;
requiring hospitalizations and less severe infection treated with &lt;br /&gt;
anti-infective agents in the primary care sector.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Main Outcomes and Measures&lt;/b&gt;&lt;br /&gt;
This study identified all mental disorders diagnosed in a &lt;br /&gt;
hospital setting and any redeemed prescription for psychotropic &lt;br /&gt;
medication. Cox proportional hazards regression was performed reporting &lt;br /&gt;
hazard rate ratios (HRRs), including 95% CIs, adjusted for age, sex, &lt;br /&gt;
somatic comorbidity, parental education, and parental mental disorders.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Results&lt;/b&gt;&lt;br /&gt;
A total of 1 098 930 individuals (51.3% male) were followed up&lt;br /&gt;
 for 9 620 807.7 person-years until a mean (SD) age of 9.76 (4.91) &lt;br /&gt;
years. Infections requiring hospitalizations were associated with &lt;br /&gt;
subsequent increased risk of having a diagnosis of any mental disorder &lt;br /&gt;
(n = 42 462) by an HRR of 1.84 (95% CI, 1.69-1.99) and with increased &lt;br /&gt;
risk of redeeming a prescription for psychotropic medication &lt;br /&gt;
(n = 56 847) by an HRR of 1.42 (95% CI, 1.37-1.46). Infection treated &lt;br /&gt;
with anti-infective agents was associated with increased risk of having a&lt;br /&gt;
 diagnosis of any mental disorder (HRR, 1.40; 95% CI, 1.29-1.51) and &lt;br /&gt;
with increased risk of redeeming a prescription for psychotropic &lt;br /&gt;
medication (HRR, 1.22; 95% CI, 1.18-1.26). Antibiotic use was associated&lt;br /&gt;
 with particularly increased risk estimates. The risk of mental &lt;br /&gt;
disorders after infections increased in a dose-response association and &lt;br /&gt;
with the temporal proximity of the last infection. In particular, &lt;br /&gt;
schizophrenia spectrum disorders, obsessive-compulsive disorder, &lt;br /&gt;
personality and behavior disorders, mental retardation, autistic &lt;br /&gt;
spectrum disorder, attention-deficit/hyperactivity disorder, &lt;br /&gt;
oppositional defiant disorder and conduct disorder, and tic disorders &lt;br /&gt;
were associated with the highest risks after infections.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Conclusions and Relevance&lt;/b&gt;&lt;br /&gt;
Although the results cannot prove causality, these findings &lt;br /&gt;
provide evidence for the involvement of infections and the immune system&lt;br /&gt;
 in the etiology of a wide range of mental disorders in children and &lt;br /&gt;
adolescents.&lt;/div&gt;
&lt;div class="blogger-post-footer"&gt;pub-5799224524264318&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><author>noreply@blogger.com (Chris Carter)</author></item><item><title>Chronic oral application of a periodontal pathogen results in brain inflammation, neurodegeneration and amyloid beta production in wild type mice. - PubMed - NCBI</title><link>http://polygenicpathways.blogspot.com/2018/10/chronic-oral-application-of-periodontal.html</link><category>Alzheimer's disease</category><category>Porphyromonas gingivalis</category><pubDate>Tue, 9 Oct 2018 15:54:00 +0100</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-9080680274793928567.post-3023037217019860979</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
&lt;div class=""&gt;
&lt;h4&gt;
BACKGROUND: &lt;/h4&gt;
The results from cross sectional &lt;br /&gt;
and longitudinal studies show that periodontitis is closely associated &lt;br /&gt;
with cognitive impairment (CI) and Alzhemer's Disease (AD). Further, &lt;br /&gt;
studies using animal model of periodontitis and human post-mortem brain &lt;br /&gt;
tissues from subjects with AD strongly suggest that a gram-negative &lt;br /&gt;
periodontal pathogen, &lt;span class="highlight" style="background-color: cyan;"&gt;Porphyromonas gingivalis&lt;/span&gt;&lt;br /&gt;
(Pg) and/or its product gingipain is/are translocated to the brain. &lt;br /&gt;
However, neuropathology resulting from Pg oral application is not known.&lt;br /&gt;
In this work, we tested the hypothesis that repeated exposure of wild &lt;br /&gt;
type C57BL/6 mice to orally administered Pg results in &lt;br /&gt;
neuroinflammation, neurodegeneration, microgliosis, astrogliosis and &lt;br /&gt;
formation of intra- and extracellular amyloid plaque and neurofibrillary&lt;br /&gt;
tangles (NFTs) which are pathognomonic signs of AD.&lt;br /&gt;
&lt;br /&gt;
&lt;h4&gt;
METHODS: &lt;/h4&gt;
Experimental&lt;br /&gt;
chronic periodontitis was induced in ten wild type 8-week old C57BL/6 &lt;br /&gt;
WT mice by repeated oral application (MWF/week) of Pg/gingipain for 22 &lt;br /&gt;
weeks (experimental group). Another 10 wild type 8-week old C57BL/6 mice&lt;br /&gt;
received vehicle alone (control group) MWF per week for 22 weeks. Brain&lt;br /&gt;
tissues were collected and the presence of Pg/gingipain was determined &lt;br /&gt;
by immunofluorescence (IF) microscopy, confocal microscopy, and &lt;br /&gt;
quantitative PCR (qPCR). The hippocampi were examined for the signs of &lt;br /&gt;
neuropathology related to AD: TNFα, IL1β, and IL6 expression &lt;br /&gt;
(neuroinflammation), NeuN and Fluoro Jade C staining (neurodegeneration)&lt;br /&gt;
and amyloid beta1-42 (Aβ42) production and phosphorylation of tau &lt;br /&gt;
protein at Ser396 were assessed by IF and confocal microscopy. Further, &lt;br /&gt;
gene expression of amyloid precursor protein (APP), beta-site APP &lt;br /&gt;
cleaving enzyme 1 (BACE1), a disintegrin and metalloproteinase &lt;br /&gt;
domain-containing protein10 (ADAM10) for α-secretase and presenilin1 &lt;br /&gt;
(PSEN1) for ɣ-secretase, and NeuN (rbFox3) were determined by RT-qPCR. &lt;br /&gt;
Microgliosis and astrogliosis were also determined by IF microscopy.&lt;br /&gt;
&lt;br /&gt;
&lt;h4&gt;
RESULTS: &lt;/h4&gt;
Pg/gingipain&lt;br /&gt;
was detected in the hippocampi of mice in the experimental group by &lt;br /&gt;
immunohistochemistry, confocal microscopy, and qPCR confirming the &lt;br /&gt;
translocation of orally applied Pg to the brain. Pg/gingipain was &lt;br /&gt;
localized intra-nuclearly and peri-nuclearly in microglia (Iba1+), &lt;br /&gt;
astrocytes (GFAP+), neurons (NeuN+) and was evident extracellularly. &lt;br /&gt;
Significantly greater levels of expression of IL6, TNFα and IL1β were &lt;br /&gt;
evident in experimental as compared to control group (p&amp;lt;0.01, &lt;br /&gt;
p&amp;lt;0.00001, p&amp;lt;0.00001 respectively). In addition, microgliosis and &lt;br /&gt;
astrogliosis were evident in the experimental but not in control group &lt;br /&gt;
(p &amp;lt;0.01, p&amp;lt;0.0001 respectively). Neurodegeneration was evident in&lt;br /&gt;
the experimental group based on a fewer number of intact neuronal cells&lt;br /&gt;
assessed by NeuN positivity and rbFOX3 gene expression, and there was a&lt;br /&gt;
greater number of degenerating neurons in the hippocampi of &lt;br /&gt;
experimental mice assessed by Fluoro Jade C positivity. APP and BACE1 &lt;br /&gt;
gene expression were increased in experimental group compared with &lt;br /&gt;
control group (p&amp;lt;0.05, p&amp;lt;0.001 respectively). PSEN1 gene &lt;br /&gt;
expression was higher in experimental than control group but the &lt;br /&gt;
difference was not statistically significant (p = 0.07). ADAM10 gene &lt;br /&gt;
expression was significantly decreased in experimental group compared &lt;br /&gt;
with control group (p&amp;lt;0.01). Extracellular Aβ42 was detected in the &lt;br /&gt;
parenchyma in the experimental but not in the control group (p&amp;lt; &lt;br /&gt;
0.00001). Finally, phospho-Tau (Ser396) protein was detected and NFTs &lt;br /&gt;
were evident in experimental but not in the control group &lt;br /&gt;
(p&amp;lt;0.00001).&lt;br /&gt;
&lt;br /&gt;
&lt;h4&gt;
CONCLUSIONS: &lt;/h4&gt;
This study is the first to &lt;br /&gt;
show neurodegeneration and the formation of extracellular Aβ42 in young &lt;br /&gt;
adult WT mice after repeated oral application of Pg. The &lt;br /&gt;
neuropathological features observed in this study strongly suggest that &lt;br /&gt;
low grade chronic periodontal pathogen infection can result in the &lt;br /&gt;
development of neuropathology that is consistent with that of AD.&lt;/div&gt;
&lt;/div&gt;
&lt;div class="blogger-post-footer"&gt;pub-5799224524264318&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><author>noreply@blogger.com (Chris Carter)</author></item><item><title>Host-parasite interaction associated with major mental illness. - PubMed - NCBI</title><link>http://polygenicpathways.blogspot.com/2018/08/host-parasite-interaction-associated.html</link><category>DISC1</category><category>gene/environment</category><category>schizophrenia</category><category>Toxoplasma gondii</category><category>Toxoplasmosis</category><pubDate>Sat, 25 Aug 2018 09:24:00 +0100</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-9080680274793928567.post-1485547604139737796</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
Clinical studies frequently report that patients with major mental &lt;br /&gt;
illness such as schizophrenia and bipolar disorder have co-morbid &lt;br /&gt;
physical conditions, suggesting that systemic alterations affecting both&lt;br /&gt;
brain and peripheral tissues might underlie the disorders. Numerous &lt;br /&gt;
studies have reported elevated levels of anti-Toxoplasma gondii (T. &lt;br /&gt;
gondii) antibodies in patients with major mental illnesses, but the &lt;br /&gt;
underlying mechanism was unclear. Using multidisciplinary &lt;br /&gt;
epidemiological, cell biological, and gene expression profiling &lt;br /&gt;
approaches, we report here multiple lines of evidence suggesting that a &lt;br /&gt;
major mental illness-related susceptibility factor, Disrupted in &lt;br /&gt;
schizophrenia (DISC1), is involved in host immune responses against T. &lt;br /&gt;
gondii infection. Specifically, our cell biology and gene expression &lt;br /&gt;
studies have revealed that DISC1 Leu607Phe variation, which changes &lt;br /&gt;
DISC1 interaction with activating transcription factor 4 (ATF4), &lt;br /&gt;
modifies gene expression patterns upon T. gondii infection. Our &lt;br /&gt;
epidemiological data have also shown that DISC1 607 Phe/Phe genotype was&lt;br /&gt;
associated with higher T. gondii antibody levels in sera. Although &lt;br /&gt;
further studies are required, our study provides mechanistic insight &lt;br /&gt;
into one of the few well-replicated serological observations in major &lt;br /&gt;
mental illness.&lt;/div&gt;
&lt;div class="blogger-post-footer"&gt;pub-5799224524264318&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><author>noreply@blogger.com (Chris Carter)</author></item><item><title>Herpesvirus may lead to bipolar, depression</title><link>http://polygenicpathways.blogspot.com/2018/08/herpesvirus-may-lead-to-bipolar.html</link><category>Bipolar disorder</category><category>depression</category><category>Herpes</category><category>HHV-6</category><pubDate>Fri, 24 Aug 2018 20:17:00 +0100</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-9080680274793928567.post-6369034215093676793</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
An international team of scientists led by Bhupesh Prusty — from the &lt;br /&gt;
Department of Microbiology at the University of Würzburg in Germany — &lt;br /&gt;
discovered that in the brains of people who lived with bipolar and major&lt;br /&gt;
depression, a class of neurons called Purkinje cells was infected with &lt;br /&gt;
the herpesvirus HHV-6A.&lt;br /&gt;
Purkinje neurons are inhibitory brain cells located in the human cerebellum, which is &lt;br /&gt;
the brain area responsible for controlling movement, muscles, balance, &lt;br /&gt;
and posture.&lt;br /&gt;
However, some research has also tied this brain region to language, cognition, and mood.&lt;br /&gt;
&lt;br /&gt;
&lt;span style="font-size: large;"&gt;&lt;span style="color: red;"&gt;Active HHV-6 Infection of Cerebellar Purkinje Cells in Mood Disorders&lt;/span&gt; &lt;/span&gt;&lt;a href="https://www.frontiersin.org/articles/10.3389/fmicb.2018.01955/full" target="_blank"&gt;Frontiers in microbiology &lt;/a&gt;&lt;/div&gt;
&lt;div class="blogger-post-footer"&gt;pub-5799224524264318&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><author>noreply@blogger.com (Chris Carter)</author></item><item><title>Plastic chemical linked to smaller prefrontal cortex, reduced cognitive ability in rats: Findings demonstrate long-term influence of endocrine-disrupting compounds on brain development -- ScienceDaily</title><link>http://polygenicpathways.blogspot.com/2018/07/plastic-chemical-linked-to-smaller.html</link><category>Endocrine disruptor</category><category>Neurodevelopmental</category><category>Phthalate</category><category>Pollution</category><pubDate>Tue, 17 Jul 2018 11:29:00 +0100</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-9080680274793928567.post-2104887514924000840</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
Adult rats that had been exposed before birth and during nursing to a &lt;br /&gt;
mixture of chemicals (Phthalates) found in a wide range of consumer products have a &lt;br /&gt;
smaller medial prefrontal cortex (mPFC) and perform worse on an &lt;br /&gt;
attention-switching task than rats not exposed to the chemicals early in&lt;br /&gt;
life. These findings, published in &lt;i&gt;JNeurosci&lt;/i&gt;, demonstrate a long-term influence of endocrine-disrupting compounds on brain development.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Daniel G. Kougias, Elli P. Sellinger, Jari Willing, Janice M. Juraska. &lt;b&gt;Perinatal&lt;br /&gt;
 exposure to an environmentally relevant mixture of phthalates results &lt;br /&gt;
in a lower number of neurons and synapses in the medial prefrontal &lt;br /&gt;
cortex and decreased cognitive flexibility in adult male and female rats&lt;/b&gt;. &lt;i&gt;The Journal of Neuroscience&lt;/i&gt;, 2018; 0607-18 DOI: &lt;a href="http://dx.doi.org/10.1523/JNEUROSCI.0607-18.2018" rel="nofollow" target="_blank"&gt;10.1523/JNEUROSCI.0607-18.2018&lt;/a&gt; &lt;/div&gt;
&lt;div class="blogger-post-footer"&gt;pub-5799224524264318&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><author>noreply@blogger.com (Chris Carter)</author></item><item><title>Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models | PNAS</title><link>http://polygenicpathways.blogspot.com/2018/07/gut-bacteria-from-multiple-sclerosis.html</link><category>Inflammation</category><category>microbiome</category><category>multiple sclerosis</category><pubDate>Sat, 14 Jul 2018 07:58:00 +0100</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-9080680274793928567.post-4284042819113072053</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
The gut microbiota regulates T cell functions throughout the body. We &lt;br /&gt;
hypothesized that intestinal bacteria impact the pathogenesis of &lt;br /&gt;
multiple sclerosis (MS), an autoimmune disorder of the CNS and thus &lt;br /&gt;
analyzed the microbiomes of 71 MS patients not undergoing treatment and &lt;br /&gt;
71 healthy controls. Although no major shifts in microbial community &lt;br /&gt;
structure were found, we identified specific bacterial taxa that were &lt;br /&gt;
significantly associated with MS. &lt;i&gt;Akkermansia muciniphila&lt;/i&gt; and &lt;i&gt;Acinetobacter calcoaceticus&lt;/i&gt;,&lt;br /&gt;
both increased in MS patients, induced proinflammatory responses in &lt;br /&gt;
human peripheral blood mononuclear cells and in monocolonized mice. In &lt;br /&gt;
contrast, &lt;i&gt;Parabacteroides distasonis&lt;/i&gt;, which was reduced in MS patients, stimulated antiinflammatory IL-10–expressing human CD4&lt;sup&gt;+&lt;/sup&gt;CD25&lt;sup&gt;+&lt;/sup&gt; T cells and IL-10&lt;sup&gt;+&lt;/sup&gt;FoxP3&lt;sup&gt;+&lt;/sup&gt;&lt;br /&gt;
Tregs in mice. Finally, microbiota transplants from MS patients into &lt;br /&gt;
germ-free mice resulted in more severe symptoms of experimental &lt;br /&gt;
autoimmune encephalomyelitis and reduced proportions of IL-10&lt;sup&gt;+&lt;/sup&gt;&lt;br /&gt;
Tregs compared with mice “humanized” with microbiota from healthy &lt;br /&gt;
controls. This study identifies specific human gut bacteria that &lt;br /&gt;
regulate adaptive autoimmune responses, suggesting therapeutic targeting&lt;br /&gt;
of the microbiota as a treatment for MS.&lt;/div&gt;
&lt;div class="blogger-post-footer"&gt;pub-5799224524264318&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><author>noreply@blogger.com (Chris Carter)</author></item><item><title>Pathway of Alzheimer's degeneration discovered: Finding is key for future treatment and earlier diagnosis -- ScienceDaily</title><link>http://polygenicpathways.blogspot.com/2018/07/pathway-of-alzheimers-degeneration.html</link><category>acetylcholine</category><category>Alzheimer's disease</category><category>Neurodegeneration</category><pubDate>Fri, 6 Jul 2018 14:04:00 +0100</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-9080680274793928567.post-3121404561821522069</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
&lt;div class="lead" id="first"&gt;
Scientists at the Montreal Neurological &lt;br /&gt;
Institute and Hospital (The Neuro) of McGill University have used a &lt;br /&gt;
unique approach to track brain degeneration in Alzheimer's disease, &lt;br /&gt;
uncovering a pathway through which degeneration spreads from one region &lt;br /&gt;
to another.&lt;/div&gt;
Individuals in the early stages of Alzheimer's disease (AD) were &lt;br /&gt;
scanned using both structural magnetic resonance imaging (sMRI) and &lt;br /&gt;
positron emission tomography (PET). The scientists were interested in &lt;br /&gt;
how AD affects the basal forebrain -- a deep brain structure that &lt;br /&gt;
supplies the outer cortex with acetylcholine, a neurotransmitter that is&lt;br /&gt;
critical for maintaining normal brain function. They found that as &lt;br /&gt;
cholinergic neurons in the basal forebrain degenerate, the areas in the &lt;br /&gt;
cortex which receive their cholinergic inputs also degenerate.&lt;/div&gt;
&lt;div class="blogger-post-footer"&gt;pub-5799224524264318&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><author>noreply@blogger.com (Chris Carter)</author></item><item><title>Exposure to paint, varnish, other solvents linked to increased risk of MS -- ScienceDaily</title><link>http://polygenicpathways.blogspot.com/2018/07/exposure-to-paint-varnish-other.html</link><category>gene/environment</category><category>multiple sclerosis</category><category>Pollution</category><pubDate>Wed, 4 Jul 2018 10:36:00 +0100</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-9080680274793928567.post-1560969024431566523</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
People who have been exposed to paint, varnish and other solvents and &lt;br /&gt;
who also carry genes that make them more susceptible to developing &lt;br /&gt;
multiple sclerosis (MS) may be at much greater risk of developing the &lt;br /&gt;
disease than people who have only the exposure to solvents or the MS &lt;br /&gt;
genes, according to a study published in the July 3, 2018, online issue &lt;br /&gt;
of &lt;i&gt;Neurology&lt;/i&gt;®, the medical journal of the American Academy of Neurology.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Anna Karin Hedström, Ola Hössjer, Michail Katsoulis, Ingrid Kockum, Tomas Olsson, Lars Alfredsson. &lt;b&gt;Organic solvents and MS susceptibility Interaction with MS risk HLA genes&lt;/b&gt;. &lt;i&gt;Neurology&lt;/i&gt;, 2018 DOI: &lt;a href="http://dx.doi.org/10.1212/WNL.0000000000005906" rel="nofollow" target="_blank"&gt;10.1212/WNL.0000000000005906&lt;/a&gt; &lt;/div&gt;
&lt;div class="blogger-post-footer"&gt;pub-5799224524264318&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><author>noreply@blogger.com (Chris Carter)</author></item><item><title>Exposure to fracking chemicals and wastewater spurs fat cell development: Researchers saw increases in the size and number of fat cells in laboratory models following exposure, even at diluted concentrations. -- ScienceDaily</title><link>http://polygenicpathways.blogspot.com/2018/06/exposure-to-fracking-chemicals-and.html</link><category>fracking</category><category>obesity</category><category>Pollution</category><pubDate>Fri, 22 Jun 2018 11:28:00 +0100</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-9080680274793928567.post-2532549883288861371</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
&lt;div class="lead" id="first"&gt;
Exposure to fracking chemicals and wastewater&lt;br /&gt;
promotes fat cell development, or adipogenesis, in living cells in a &lt;br /&gt;
laboratory, according to a new Duke University-led study.&lt;/div&gt;
Researchers observed increases in both the size and number of fat &lt;br /&gt;
cells after exposing living mouse cells in a dish to a mixture of 23 &lt;br /&gt;
commonly used fracking chemicals. They also observed these effects after&lt;br /&gt;
exposing the cells to samples of wastewater from fracked oil and gas &lt;br /&gt;
wells and surface water believed to be contaminated with the wastewater.&lt;br /&gt;
The findings appear June 21 in &lt;a href="https://www.sciencedirect.com/science/article/pii/S0048969718316620" target="_blank"&gt;Science of the Total Environment&lt;/a&gt;.&lt;/div&gt;
&lt;div class="blogger-post-footer"&gt;pub-5799224524264318&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><author>noreply@blogger.com (Chris Carter)</author></item><item><title>Herpes Viruses Implicated in Alzheimer’s Disease</title><link>http://polygenicpathways.blogspot.com/2018/06/herpes-viruses-implicated-in-alzheimers.html</link><category>Alzheimer's disease</category><category>Herpes</category><category>HHV-6</category><category>HHV-7</category><pubDate>Thu, 21 Jun 2018 20:24:00 +0100</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-9080680274793928567.post-8451533591659739992</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
&lt;span class="dropcap"&gt;T&lt;/span&gt;he brains of Alzheimer’s disease patients have an abnormal build up of amyloid-β proteins and tau tangles, which, according to many researchers, drives the ultimately fatal cognitive disease. This theory is being amended to a newer one, which posits that microbes may trigger Alzheimer’s pathology. Two new studies, using different approaches, further bolster this pathogen theory. Analyzing the transcriptomes of post-mortem brain samples from patients with Alzheimer’s disease, one group of researchers finds that two strains of human herpes virus (&lt;i&gt;Roseoloviruses &lt;/i&gt;HHV-6 and HHV-7) are significantly more abundant than in the brains of people of the same age without Alzheimer’s disease. Gene networks in the brains of Alzheimer’s patients with these strains are also rewired such that disease-related genes are differentially expressed compared to controls.&lt;br /&gt;
&lt;br /&gt;
In the other study, another team of investigators observed in mouse models and in a three-dimensional human neuronal cell culture that a Herpesviridae infection could seed amyloid-β plaques.&lt;/div&gt;
&lt;div class="blogger-post-footer"&gt;pub-5799224524264318&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><author>noreply@blogger.com (Chris Carter)</author></item><item><title>NIH-supported researchers find link between allergen in red meat and heart disease | National Institutes of Health (NIH)</title><link>http://polygenicpathways.blogspot.com/2018/06/nih-supported-researchers-find-link.html</link><category>Allergen</category><category>atherosclerosis</category><category>heart disease</category><pubDate>Thu, 14 Jun 2018 16:09:00 +0100</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-9080680274793928567.post-1156821665146681600</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
Only in recent years did scientists identify the main allergen in red&lt;br /&gt;
meat, called galactose-α-1,3-galactose, or alpha-Gal, a type of complex&lt;br /&gt;
sugar. They also found that a tick — the Lone Star tick — sensitizes &lt;br /&gt;
people to this allergen when it bites them. That is why red meat &lt;br /&gt;
allergies tend to be more common where these ticks are more prevalent, &lt;br /&gt;
such as the Southeastern United States, but also extending to other &lt;br /&gt;
areas, including Long Island, New York.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Researchers have suspected for some time that allergens can trigger &lt;br /&gt;
certain immunological changes that might be associated with plaque &lt;br /&gt;
buildup and artery blockages, but no one had identified a specific &lt;br /&gt;
substance that is responsible for this effect. In the current study, &lt;br /&gt;
researchers showed for the first time that a specific blood marker for &lt;br /&gt;
red meat allergy was associated with higher levels of arterial plaque, &lt;br /&gt;
or fatty deposits on the inner lining of the arteries. The blood marker &lt;br /&gt;
they identified is a type of antibody (immunoglobulin or IgE) that is &lt;br /&gt;
specific to the alpha-Gal allergen.&lt;/div&gt;
&lt;div class="blogger-post-footer"&gt;pub-5799224524264318&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><author>noreply@blogger.com (Chris Carter)</author></item><item><title>Bacteriophages: Are they an overlooked driver of Parkinson's disease? | EurekAlert! Science News</title><link>http://polygenicpathways.blogspot.com/2018/06/bacteriophages-are-they-overlooked.html</link><category>microbiome</category><category>Parkinson's disease</category><pubDate>Wed, 13 Jun 2018 09:22:00 +0100</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-9080680274793928567.post-918210919319983249</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
In the first study of its kind, researchers from the New York-based &lt;br /&gt;
Human Microbiology Institute have discovered the role certain &lt;br /&gt;
bacteriophages may play in the onset of Parkinson's disease (PD). The &lt;br /&gt;
research is presented at ASM Microbe, the annual meeting of the American&lt;br /&gt;
Society for Microbiology, held from June 7th to June 11th in Atlanta, &lt;br /&gt;
Georgia.&lt;br /&gt;
The researchers, led by George, Tetz, M.D., Ph.D., Human Microbiology Institute, showed that the abundance of lytic &lt;i&gt;Lactococcus&lt;/i&gt; phages was higher in PD patients when compared to healthy individuals.This abundance led to a 10-fold reduction in neurotransmitter-producing &lt;i&gt;Lactococcus&lt;/i&gt;,&lt;br /&gt;
suggesting the possible role of phages in neurodegeneration. &lt;br /&gt;
Comparative analysis of the bacterial component also revealed &lt;br /&gt;
significant decreases in &lt;i&gt;Streptococcus&lt;/i&gt; spp. and &lt;i&gt;Lactobacillus&lt;/i&gt; spp. in PD.&lt;br /&gt;
&lt;i&gt;Lactococcus&lt;/i&gt; are regulators of gut permeability and are &lt;br /&gt;
enteric dopamine producers, which plays a primary role in PD. "The &lt;br /&gt;
depletion of lactococcus due to high numbers of strictly lytic phages in&lt;br /&gt;
PD patients might be associated with PD development and directly linked&lt;br /&gt;
to dopamine decrease as well as the development of gastrointestinal &lt;br /&gt;
symptoms of PD," said Dr. Tetz.&lt;/div&gt;
&lt;div class="blogger-post-footer"&gt;pub-5799224524264318&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><author>noreply@blogger.com (Chris Carter)</author></item><item><title>Drugs that suppress immune system may protect against Parkinson's: People who take immunosuppressants less likely to develop the disease -- ScienceDaily</title><link>http://polygenicpathways.blogspot.com/2018/06/drugs-that-suppress-immune-system-may.html</link><category>Immune system</category><category>immunosuppressant</category><category>Parkinson's disease</category><pubDate>Fri, 1 Jun 2018 11:13:00 +0100</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-9080680274793928567.post-8236202779446584838</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
Racette and colleagues analyzed Medicare Part D prescription drug &lt;br /&gt;
data on 48,295 people diagnosed with Parkinson's in 2009 and 52,324 &lt;br /&gt;
people never diagnosed with Parkinson's. They identified 26 commonly &lt;br /&gt;
prescribed immunosuppressant drugs, representing six classes of &lt;br /&gt;
medications. The researchers determined which people in the data set had&lt;br /&gt;
been prescribed any of the drugs a year or more before the date of &lt;br /&gt;
diagnosis or by a pre-set cutoff date. Prescriptions written in the 12 &lt;br /&gt;
months before diagnosis or by the cutoff were excluded to rule out any &lt;br /&gt;
chance that the prescriptions might have been linked to early signs of &lt;br /&gt;
the disease.&lt;br /&gt;
The researchers found that people taking drugs in either of two &lt;br /&gt;
classes were significantly less likely to develop Parkinson's than those&lt;br /&gt;
taking no immunosuppressants. People taking corticosteroids such as &lt;br /&gt;
prednisone were 20 percent less likely to be diagnosed with Parkinson's,&lt;br /&gt;
while those on inosine monophosphate dehydrogenase (IMDH) inhibitors &lt;br /&gt;
were about one-third less likely.&lt;br /&gt;
&lt;br /&gt;
Here's the paper:- &lt;br /&gt;
&lt;br /&gt;
&lt;a href="https://onlinelibrary.wiley.com/doi/10.1002/acn3.580" target="_blank"&gt;&lt;strong&gt;Immunosuppressants and Risk of Parkinson Disease&lt;/strong&gt;&lt;/a&gt;. &lt;em&gt;Annals of Clinical and Translational Neurology&lt;/em&gt;, May 31, 2018 &lt;/div&gt;
&lt;div class="blogger-post-footer"&gt;pub-5799224524264318&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><author>noreply@blogger.com (Chris Carter)</author></item><item><title>Convergence of placenta biology and genetic risk for schizophrenia | Nature Medicine</title><link>http://polygenicpathways.blogspot.com/2018/05/convergence-of-placenta-biology-and.html</link><category>Placenta</category><category>Pregnancy</category><category>schizophrenia</category><pubDate>Tue, 29 May 2018 11:49:00 +0100</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-9080680274793928567.post-2487686554444006036</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
Defining the environmental context in which genes enhance disease &lt;br /&gt;
susceptibility can provide insight into the pathogenesis of complex &lt;br /&gt;
disorders. We report that the intra-uterine environment modulates the &lt;br /&gt;
association of schizophrenia with genomic risk (in this study, &lt;br /&gt;
genome-wide association study–derived polygenic risk scores (PRSs)). In &lt;br /&gt;
independent samples from the United States, Italy, and Germany, the &lt;br /&gt;
liability of schizophrenia explained by PRS is more than five times &lt;br /&gt;
greater in the presence of early-life complications (ELCs) compared with&lt;br /&gt;
their absence. Patients with ELC histories have significantly higher &lt;br /&gt;
PRS than patients without ELC histories, which is confirmed in &lt;br /&gt;
additional samples from Germany and Japan. The gene set composed of &lt;br /&gt;
schizophrenia loci that interact with ELCs is highly expressed in &lt;br /&gt;
placenta, is differentially expressed in placentae from complicated in &lt;br /&gt;
comparison with normal pregnancies, and is differentially upregulated in&lt;br /&gt;
placentae from male compared with female offspring. Pathway analyses &lt;br /&gt;
reveal that genes driving the PRS-ELC interaction are involved in &lt;br /&gt;
cellular stress response; genes that do not drive such interaction &lt;br /&gt;
implicate orthogonal biological processes (for example, synaptic &lt;br /&gt;
function). We conclude that a subset of the most significant genetic &lt;br /&gt;
variants associated with schizophrenia converge on a developmental &lt;br /&gt;
trajectory sensitive to events that affect the placental response to &lt;br /&gt;
stress, which may offer insights into sex biases and primary prevention.&lt;/div&gt;
&lt;div class="blogger-post-footer"&gt;pub-5799224524264318&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><author>noreply@blogger.com (Chris Carter)</author></item><item><title>Infection of Fungi and Bacteria in Brain Tissue From Elderly Persons and Patients With Alzheimer’s Disease | Frontiers in Aging Neuroscience</title><link>http://polygenicpathways.blogspot.com/2018/05/infection-of-fungi-and-bacteria-in.html</link><category>Alzheimer's disease</category><category>bacteria</category><category>Fungus</category><pubDate>Mon, 28 May 2018 13:20:00 +0100</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-9080680274793928567.post-5244800873290231261</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
Alzheimer’s disease (AD) is the leading cause of dementia in elderly &lt;br /&gt;
people. The etiology of this disease remains a matter of intensive &lt;br /&gt;
research in many laboratories. We have advanced the idea that &lt;br /&gt;
disseminated fungal infection contributes to the etiology of AD. Thus, &lt;br /&gt;
we have demonstrated that fungal proteins and DNA are present in nervous&lt;br /&gt;
tissue from AD patients. More recently, we have reported that bacterial&lt;br /&gt;
infections can accompany these mycoses, suggesting that polymicrobial &lt;br /&gt;
infections exist in AD brains. In the present study, we have examined &lt;br /&gt;
fungal and bacterial infection in brain tissue from AD patients and &lt;br /&gt;
control subjects by immunohistochemistry. In addition, we have &lt;br /&gt;
documented the fungal and bacterial species in brain regions from AD &lt;br /&gt;
patients and control subjects by next-generation sequencing (NGS). Our &lt;br /&gt;
results from the analysis of ten AD patients reveal a variety of fungal &lt;br /&gt;
and bacterial species, although some were more prominent than others. &lt;br /&gt;
The fungal genera more prevalent in AD patients were &lt;i&gt;Alternaria&lt;/i&gt;, &lt;i&gt;Botrytis&lt;/i&gt;, &lt;i&gt;Candida&lt;/i&gt;, and &lt;i&gt;Malassezia&lt;/i&gt;.&lt;br /&gt;
We also compared these genera with those found in elderly and younger &lt;br /&gt;
subjects. One of the most prominent genera in control subjects was &lt;i&gt;Fusarium&lt;/i&gt;.&lt;br /&gt;
Principal component analysis clearly indicated that fungi from frontal &lt;br /&gt;
cortex samples of AD brains clustered together and differed from those &lt;br /&gt;
of equivalent control subjects. Regarding bacterial infection, the &lt;br /&gt;
phylum &lt;i&gt;Proteobacteria&lt;/i&gt; was the most prominent in both AD patients and controls, followed by &lt;i&gt;Firmicutes&lt;/i&gt;, &lt;i&gt;Actinobacteria&lt;/i&gt;, and &lt;i&gt;Bacteroides&lt;/i&gt;. At the family level, &lt;i&gt;Burkholderiaceae&lt;/i&gt; and &lt;i&gt;Staphylococcaceae&lt;/i&gt;&lt;br /&gt;
exhibited higher percentages in AD brains than in control brains. These&lt;br /&gt;
findings could be of interest to guide targeted antimicrobial therapy &lt;br /&gt;
for AD patients. Moreover, the variety of microbial species in each &lt;br /&gt;
patient may constitute a basis for a better understanding of the &lt;br /&gt;
evolution and severity of clinical symptoms in each patient.&lt;/div&gt;
&lt;div class="blogger-post-footer"&gt;pub-5799224524264318&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><author>noreply@blogger.com (Chris Carter)</author></item><item><title>Cause of pesticide exposure, Parkinson's link: Low-level exposure to the pesticides disrupts cells in a way that mimics the effects of mutations known to cause Parkinson's disease -- ScienceDaily</title><link>http://polygenicpathways.blogspot.com/2018/05/cause-of-pesticide-exposure-parkinsons.html</link><category>gene/environment</category><category>Paraquat</category><category>Parkinson's disease</category><category>pesticide</category><pubDate>Thu, 24 May 2018 12:06:00 +0100</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-9080680274793928567.post-7786428494520694258</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
Previous studies have found an association between two commonly used &lt;br /&gt;
agrochemicals (paraquat and maneb) and Parkinson's disease. Now a &lt;br /&gt;
professor has determined that low-level exposure to the pesticides &lt;br /&gt;
disrupts cells in a way that mimics the effects of mutations known to &lt;br /&gt;
cause Parkinson's disease. Adding the effects of the chemicals to a &lt;br /&gt;
predisposition for Parkinson's disease drastically increases the risk of&lt;br /&gt;
disease onset.&lt;br /&gt;
&lt;br /&gt;
From this Paper:- &lt;br /&gt;
&lt;strong&gt;Nitration of microtubules blocks axonal mitochondrial transport in a human pluripotent stem cell model of Parkinson’s disease&lt;/strong&gt;. &lt;em&gt;The FASEB Journal&lt;/em&gt;, 2018; fj.201700759RR DOI: &lt;a href="http://dx.doi.org/10.1096/fj.201700759RR" rel="nofollow" target="_blank"&gt;10.1096/fj.201700759RR&lt;/a&gt; &lt;/div&gt;
&lt;div class="blogger-post-footer"&gt;pub-5799224524264318&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><author>noreply@blogger.com (Chris Carter)</author></item><item><title>Transcriptome analysis in whole blood reveals increased microbial diversity in schizophrenia | Translational Psychiatry</title><link>http://polygenicpathways.blogspot.com/2018/05/transcriptome-analysis-in-whole-blood.html</link><category>Immune system</category><category>microbiome</category><category>schizophrenia</category><pubDate>Thu, 24 May 2018 09:28:00 +0100</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-9080680274793928567.post-2992944819160957279</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
The role of the human microbiome in health and disease is increasingly &lt;br /&gt;
appreciated. We studied the composition of microbial communities present&lt;br /&gt;
in blood across 192 individuals, including healthy controls and &lt;br /&gt;
patients with three disorders affecting the brain: schizophrenia, &lt;br /&gt;
amyotrophic lateral sclerosis, and bipolar disorder. By using &lt;br /&gt;
high-quality unmapped RNA sequencing reads as candidate microbial reads,&lt;br /&gt;
we performed profiling of microbial transcripts detected in whole &lt;br /&gt;
blood. We were able to detect a wide range of bacterial and archaeal &lt;br /&gt;
phyla in blood. Interestingly, we observed an increased microbial &lt;br /&gt;
diversity in schizophrenia patients compared to the three other groups. &lt;br /&gt;
We replicated this finding in an independent schizophrenia case–control &lt;br /&gt;
cohort. This increased diversity is inversely correlated with estimated &lt;br /&gt;
cell abundance of a subpopulation of CD8&lt;sup&gt;+&lt;/sup&gt; memory T cells in healthy controls, supporting a link between microbial products found in blood, immunity and schizophrenia.&lt;/div&gt;
&lt;div class="blogger-post-footer"&gt;pub-5799224524264318&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><author>noreply@blogger.com (Chris Carter)</author></item><item><title>Minimizing exposure to common hormone-disrupting chemicals may reduce obesity rates -- ScienceDaily</title><link>http://polygenicpathways.blogspot.com/2018/05/minimizing-exposure-to-common-hormone.html</link><category>Endocrine disruptor</category><category>obesity</category><category>Pollution</category><pubDate>Tue, 22 May 2018 14:48:00 +0100</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-9080680274793928567.post-2820601597945594583</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
Everyday products carry environmental chemicals that may be making us &lt;br /&gt;
fat by interfering with our hormones, according to research presented in&lt;br /&gt;
Barcelona at the European Society of Endocrinology annual meeting, ECE &lt;br /&gt;
2018. Following recommendations on how to avoid these chemicals could &lt;br /&gt;
help minimise exposure and potentially reduce the risk of obesity and &lt;br /&gt;
its complications.&lt;/div&gt;
&lt;div class="blogger-post-footer"&gt;pub-5799224524264318&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><author>noreply@blogger.com (Chris Carter)</author></item><item><title>Most common childhood cancer 'partly caused by lack of infection' | Society | The Guardian</title><link>http://polygenicpathways.blogspot.com/2018/05/most-common-childhood-cancer-partly.html</link><category>cancer</category><category>Leukemia</category><category>microbiome</category><pubDate>Tue, 22 May 2018 10:48:00 +0100</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-9080680274793928567.post-1046293719247509426</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
Clean modern homes, antiseptic wipes and the understandable desire to&lt;br /&gt;
protect small babies against any infection are all part of the cause of&lt;br /&gt;
the most common form of childhood cancer, a leading expert has &lt;br /&gt;
concluded after more than 30 years of research.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Childhood acute leukaemia, says the highly respected Prof Mel &lt;br /&gt;
Greaves, is nothing to do with power lines or nuclear fuel reprocessing &lt;br /&gt;
stations. Nor is it to do with hot dogs and hamburgers or the Vatican &lt;br /&gt;
radio mast, as have also been suggested. After the best part of a &lt;br /&gt;
century of speculation, some of it with little basis in science, Greaves&lt;br /&gt;
– who recently won the Royal Society’s prestigious Royal Medal – says &lt;br /&gt;
the cancer is caused by a combination of genetic mutations and a lack of&lt;br /&gt;
childhood infection. &lt;br /&gt;
The best news, says Greaves, is that the cancer is likely to be &lt;br /&gt;
preventable. And part of the answer could be to ensure children under &lt;br /&gt;
the age of one have social contact with others, possibly at daycare &lt;br /&gt;
centres.&lt;br /&gt;
Greaves, from the Institute of Cancer&lt;br /&gt;
Research in London, has compiled evidence from decades of work on acute&lt;br /&gt;
lymphoblastic leukaemia (ALL), which affects one in 2,000 children. In &lt;br /&gt;
the 1950s and 1960s, it was lethal. Today, 90% of children are cured, &lt;br /&gt;
although the treatment is lengthy and toxic and can have long-term &lt;br /&gt;
consequences.&lt;/div&gt;
&lt;div class="blogger-post-footer"&gt;pub-5799224524264318&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><author>noreply@blogger.com (Chris Carter)</author></item><item><title>Prolonged exposure to air pollution leads to genetic changes in rat brains, study finds: Insight into potential health effects of dirty air in the Los Angeles basin -- ScienceDaily</title><link>http://polygenicpathways.blogspot.com/2018/05/prolonged-exposure-to-air-pollution.html</link><category>cancer</category><category>Particulate matter</category><category>Pollution</category><pubDate>Wed, 9 May 2018 12:34:00 +0100</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-9080680274793928567.post-3898922750323519333</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
&lt;div class="lead" id="first"&gt;
Prolonged exposure to particulate matter in &lt;br /&gt;
air pollution in the Los Angeles Basin triggered inflammation and the &lt;br /&gt;
appearance of cancer-related genes in the brains of rats, a Cedars-Sinai&lt;br /&gt;
study has found.&lt;/div&gt;
While previous research has documented the association between air &lt;br /&gt;
pollution and a variety of diseases, including cancer, the study found &lt;br /&gt;
markers indicating certain materials in coarse air pollution -- nickel, &lt;br /&gt;
in particular -- may play a role in genetic changes related to disease &lt;br /&gt;
development, said Julia Ljubimova, MD, PhD.&lt;/div&gt;
&lt;div class="blogger-post-footer"&gt;pub-5799224524264318&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><author>noreply@blogger.com (Chris Carter)</author></item><item><title>Reaction of Amyloid-β Peptide Antibody with Different Infectious Agents Involved in Alzheimer’s Disease - IOS Press</title><link>http://polygenicpathways.blogspot.com/2018/04/reaction-of-amyloid-peptide-antibody.html</link><category>Alzheimer's disease</category><category>Autoantibody</category><category>bacteria</category><category>Beta amyloid</category><category>molecular mimicry</category><pubDate>Thu, 26 Apr 2018 20:50:00 +0100</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-9080680274793928567.post-5531074050348898081</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
As early as the 1980s, molecular virologist Ruth Itzhaki began to &lt;br /&gt;
investigate if there was a causal connection between infections and &lt;br /&gt;
neurodegenerative disorder. Although the theory has yet to be &lt;br /&gt;
universally embraced, in 2016 Itzhaki and 33 other scientists from all &lt;br /&gt;
over the world published a revie&lt;span class="below-fold" data-below-fold="JAD170961"&gt;w&lt;br /&gt;
 article in this very journal presenting evidence for the causal role of&lt;br /&gt;
 pathogens in Alzheimer’s disease (AD). Exactly how and in what way &lt;br /&gt;
pathogens affect the induction of AD has yet to be determined, but one &lt;br /&gt;
possible answer may involve the cross-reactivity of different pathogens &lt;br /&gt;
with amyloid-β (Aβ). Aβ autoantibodies have been detected in the serum &lt;br /&gt;
and cerebrospinal fluid of AD patients and in some healthy individuals. &lt;br /&gt;
In the present study our major goal was to investigate whether &lt;br /&gt;
antibodies made against Aβ would react both with other brain proteins as&lt;br /&gt;
 well as pathogens associated with AD as a result of molecular mimicry &lt;br /&gt;
or the binding of bacterial toxins to Aβ42. Our study used a specific &lt;br /&gt;
monoclonal antibody made against Aβ42, which not only reacted strongly &lt;br /&gt;
with Aβ42, tau protein, and α-synuclein, but also had from weak to &lt;br /&gt;
strong reactions with 25 different pathogens or their molecules, some of&lt;br /&gt;
 which have been associated with AD. The homology between peptide &lt;br /&gt;
stretches of microbial origin and proteins involved in AD could be a &lt;br /&gt;
mechanism by which antibodies to homologous peptides mount attacks &lt;br /&gt;
against autoantigens in AD. We concluded that bacterial molecules bind &lt;br /&gt;
to Aβ protein, forming small oligomers, then encasing pathogens and &lt;br /&gt;
their molecules to form amyloid plaques, the tell-tale markers of AD. &lt;br /&gt;
Conversely, these same Aβ peptides induce the production of antibodies &lt;br /&gt;
to both Aβ42 and bacterial molecules, which may inhibit bacterial &lt;br /&gt;
pathogenesis, but in the process may promote amyloid plaque formation. &lt;/span&gt;&lt;/div&gt;
&lt;div class="blogger-post-footer"&gt;pub-5799224524264318&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><author>noreply@blogger.com (Chris Carter)</author></item></channel></rss>